Rivera López, E.; Samaniego López, C.; Spagnuolo, C.C.; Berardino, B.G.; Alaimo, A.; Pérez, O.E.
Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood–Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent. Pharmaceutics 2024, 16, 964.
https://doi.org/10.3390/pharmaceutics16070964
AMA Style
Rivera López E, Samaniego López C, Spagnuolo CC, Berardino BG, Alaimo A, Pérez OE.
Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood–Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent. Pharmaceutics. 2024; 16(7):964.
https://doi.org/10.3390/pharmaceutics16070964
Chicago/Turabian Style
Rivera López, Emilio, Cecilia Samaniego López, Carla C. Spagnuolo, Bruno G. Berardino, Agustina Alaimo, and Oscar E. Pérez.
2024. "Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood–Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent" Pharmaceutics 16, no. 7: 964.
https://doi.org/10.3390/pharmaceutics16070964
APA Style
Rivera López, E., Samaniego López, C., Spagnuolo, C. C., Berardino, B. G., Alaimo, A., & Pérez, O. E.
(2024). Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood–Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent. Pharmaceutics, 16(7), 964.
https://doi.org/10.3390/pharmaceutics16070964